Across TCGA pan-cancer cohorts, MIR513B RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR513B’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where MIR513B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR513B is over-expressed in tumor.
KIRP and KIRC are the cancer types where MIR513B tumor–normal differential expression is most reproducible.